STAN® fetal heart monitor

The use of STAN® significantly decreases the risk of fetal distress, especially by providing detailed information when the fetus is threatened by hypoxia during labour. At the same time the number of unnecessary artificial deliveries decreases if compared to exclusive CTG monitoring. This makes STAN the optimal solution for the detection of changes that are related to the risk of fetal hypoxia. At this moment the major part of the delivery wards Benelux are using STAN. BMA is the offical STAN distributor in the Benelux.



For more information, please contact Rob Hogeweg via


better care
0 weeks
40 weeks
48 weeks